Merck KGaA mulls sale of undersized consumer health unit

Fierce Pharma ------ Biosimilars may not be the only business Merck KGaA divests in 2017.The German drugmaker is weighing options for its consumer health business, it said Tuesday, and a partial or full sale is on the table. The company is also open to strategic partnerships, it said. The reason? “We expect increasing internal constraints to fund the business to reach the required scale,” Belén Garijo, the company’s healthcare CEO, said in a statement, adding that “any possible proceeds from a potential transaction would be used to deliver on the company’s overall financial targets.” To learn more click on the picture below to read the article.